Learn More
Medchemexpress LLC Tivozanib hydrochloride hydrate | 682745-41-1 | 99.8% | 509.34 | 10 MM 1 ML

Supplier: Medchemexpress LLC HY10977A10MG
Tivozanib hydrochloride hydrate is the hydrate hydrochloride form of Tivozanib. It is a selective, orally active inhibitor for vascular endothelial growth factor receptor (VEGFR)-1, 2, and 3. This compound exhibits antitumor efficacy.
- Selective, orally active inhibitor for VEGFR-1, 2, and 3
- Exhibits antitumor efficacy
- Available in solid form, white to off-white color
- Soluble in DMSO (125 mg/mL)
- Inhibits the phosphorylation of VEGFR-1, VEGFR-2, and VEGFR-3
- Inhibits VEGF-induced proliferation and migration of HUVECs
- Selectively inhibits VEGF-stimulated phosphorylation of MAPKs in endothelial cells
- Exhibits antitumor efficacy against various cancers in athymic mice models
- Reversibly suppresses vascular permeability and angiogenesis in tumor-bearing rats
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.